Identification of Immunoreactive Peptides of Toxins to Simultaneously Assess the Neutralization Potency of Antivenoms Against Neurotoxicity and Cytotoxicity of Naja Atra Venom

Overview

Journal Toxins (Basel)

Publisher MDPI

Specialty Toxicology

Date 2018 Jan 4

PMID 29295601

Citations 11

Authors

Bin-Sin Liu

Wen-Guey Wu

Min-Han Lin

Chi-Han Li

Bo-Rong Jiang

Suh-Chin Wu

Chih-Hsiang Leng

Wang-Chou Sung

Affiliations

Soon will be listed here.

Abstract

Assessing the neutralization capability of nonlethal but medically relevant toxins in venom has been a challenging task. Nowadays, neutralization efficacy is evaluated based simply on the survival rates of animals injected with antivenom together with a predefined dose of venom, which can determine potency against neurotoxicity but not validate the capability to neutralize cytotoxin-induced complications. In this study, a high correlation with in-vivo and in-vitro neutralization assays was established using the immunoreactive peptides identified from short-chain neurotoxin and cytotoxin A3. These peptides contain conserved residues associated with toxin activities and a competition assay indicated that these peptides could specifically block the antibody binding to toxin and affect the neutralization potency of antivenom. Moreover, the titers of peptide-specific antibody in antivenoms or mouse antisera were determined by enzyme-linked immunosorbent assay (ELISA) simultaneously, and the results indicated that Taiwanese bivalent antivenom (BAV) and Vietnamese snake antivenom-Naja (SAV-Naja) exhibited superior neutralization potency against the lethal effect of short-chain neurotoxin (sNTX) and cytotoxicity of cardiotoxin/cytotoxin (CTX), respectively. Thus, the reported peptide ELISA shows not only its potential for antivenom prequalification use, but also its capability of justifying the cross-neutralization potency of antivenoms against venom toxicity.

Citing Articles

Snakebite Envenoming in Avian Species: A Systematic Scoping Review and Practitioner Experience Survey.

Cummings C, Eisenbarth J J Avian Med Surg. 2023; 37(2):118-131.

PMID: 37733451 PMC: 10787666. DOI: 10.1647/22-00035.

Unveiling the functional epitopes of cobra venom cytotoxin by immunoinformatics and epitope-omic analyses.

Hiu J, Fung J, Tan H, Yap M Sci Rep. 2023; 13(1):12271.

PMID: 37507457 PMC: 10382524. DOI: 10.1038/s41598-023-39222-2.

Antivenom preclinical efficacy testing against Asian snakes and their availability in Asia: A systematic review.

Soopairin S, Patikorn C, Taychakhoonavudh S PLoS One. 2023; 18(7):e0288723.

PMID: 37467278 PMC: 10355433. DOI: 10.1371/journal.pone.0288723.

Taiwan cobra envenoming: serum venom concentration before and after specific treatment and relationship with debridement of necrotic wound tissue.

Wang C, Ou Yang C, Hsu C, Liu C, Yu J, Lo C J Venom Anim Toxins Incl Trop Dis. 2023; 29:e20220027.

PMID: 36721427 PMC: 9851669. DOI: 10.1590/1678-9199-JVATITD-2022-0027.

Cytotoxicity of Venoms and Cytotoxins from Asiatic Cobras (, , ) and Neutralization by Antivenoms from Thailand, Vietnam, and Taiwan.

Chong H, Tan K, Liu B, Sung W, Tan C Toxins (Basel). 2022; 14(5).

PMID: 35622581 PMC: 9144634. DOI: 10.3390/toxins14050334.

References

Forouhar F, Huang W, Liu J, Chien K, Wu W, Hsiao C . Structural basis of membrane-induced cardiotoxin A3 oligomerization. J Biol Chem. 2003; 278(24):21980-8. DOI: 10.1074/jbc.M208650200. View

Herrera M, Paiva O, Pagotto A, Segura A, Serrano S, Vargas M . Antivenomic characterization of two antivenoms against the venom of the taipan, Oxyuranus scutellatus, from Papua New Guinea and Australia. Am J Trop Med Hyg. 2014; 91(5):887-94. PMC: 4228881. DOI: 10.4269/ajtmh.14-0333. View

. Progress in the characterization of venoms and standardization of antivenoms. WHO Offset Publ. 1981; (58):1-44. View

Lomonte B, Escolano J, Fernandez J, Sanz L, Angulo Y, Gutierrez J . Snake venomics and antivenomics of the arboreal neotropical pitvipers Bothriechis lateralis and Bothriechis schlegelii. J Proteome Res. 2008; 7(6):2445-57. DOI: 10.1021/pr8000139. View

Pla D, Paiva O, Sanz L, Beutler M, Wright C, Calvete J . Preclinical efficacy of Australian antivenoms against the venom of the small-eyed snake, Micropechis ikaheka, from Papua New Guinea: an antivenomics and neutralization study. J Proteomics. 2014; 110:198-208. DOI: 10.1016/j.jprot.2014.06.016. View

Leong P, Sim S, Fung S, Sumana K, Sitprija V, Tan N . Cross neutralization of Afro-Asian cobra and Asian krait venoms by a Thai polyvalent snake antivenom (Neuro Polyvalent Snake Antivenom). PLoS Negl Trop Dis. 2012; 6(6):e1672. PMC: 3367981. DOI: 10.1371/journal.pntd.0001672. View

Su H, Wang M, Li Y, Tang C, Tsai M . Can surgical need in patients with (Taiwan or Chinese cobra) envenomation be predicted in the emergency department?. Hong Kong Med J. 2016; 22(5):435-44. DOI: 10.12809/hkmj154739. View

Tan N, Wong K, Tan C . Venomics of Naja sputatrix, the Javan spitting cobra: A short neurotoxin-driven venom needing improved antivenom neutralization. J Proteomics. 2017; 157:18-32. DOI: 10.1016/j.jprot.2017.01.018. View

Jiang Y, Li Y, Lee W, Xu X, Zhang Y, Zhao R . Venom gland transcriptomes of two elapid snakes (Bungarus multicinctus and Naja atra) and evolution of toxin genes. BMC Genomics. 2011; 12:1. PMC: 3023746. DOI: 10.1186/1471-2164-12-1. View

10.

Huang H, Liu B, Chien K, Chiang L, Huang S, Sung W . Cobra venom proteome and glycome determined from individual snakes of Naja atra reveal medically important dynamic range and systematic geographic variation. J Proteomics. 2015; 128:92-104. DOI: 10.1016/j.jprot.2015.07.015. View

11.

Wang P, Loh K, Lin S, Chien T, Chiang J, Hsieh W . Consensus sequence L/PKSSLL mimics crucial epitope on Loop III of Taiwan cobra cardiotoxin. Biochem Biophys Res Commun. 2009; 387(3):617-22. DOI: 10.1016/j.bbrc.2009.07.097. View

12.

Mirtschin P, Dunstan N, Hough B, Hamilton E, Klein S, Lucas J . Venom yields from Australian and some other species of snakes. Ecotoxicology. 2006; 15(6):531-8. DOI: 10.1007/s10646-006-0089-x. View

13.

Tan K, Tan C, Fung S, Tan N . Venomics, lethality and neutralization of Naja kaouthia (monocled cobra) venoms from three different geographical regions of Southeast Asia. J Proteomics. 2015; 120:105-25. DOI: 10.1016/j.jprot.2015.02.012. View

14.

Rungsiwongse J, Ratanabanangkoon K . Development of an ELISA to assess the potency of horse therapeutic antivenom against Thai cobra venom. J Immunol Methods. 1991; 136(1):37-43. DOI: 10.1016/0022-1759(91)90247-d. View

15.

Theakston R, Warrell D . Antivenoms: a list of hyperimmune sera currently available for the treatment of envenoming by bites and stings. Toxicon. 1991; 29(12):1419-70. DOI: 10.1016/0041-0101(91)90002-9. View

16.

Maria W, Cambuy M, Costa J, Velarde D, Chavez-Olortegui C . Neutralizing potency of horse antibothropic antivenom. Correlation between in vivo and in vitro methods. Toxicon. 1998; 36(10):1433-9. DOI: 10.1016/s0041-0101(98)00077-4. View

17.

Lomonte B . Identification of linear B-cell epitopes on myotoxin II, a Lys49 phospholipase A₂ homologue from Bothrops asper snake venom. Toxicon. 2012; 60(5):782-90. DOI: 10.1016/j.toxicon.2012.05.028. View

18.

Castro K, Duarte C, Ramos H, Machado de Avila R, Schneider F, Oliveira D . Identification and characterization of B-cell epitopes of 3FTx and PLA(2) toxins from Micrurus corallinus snake venom. Toxicon. 2014; 93:51-60. DOI: 10.1016/j.toxicon.2014.10.015. View

19.

Villalta M, Pla D, Yang S, Sanz L, Segura A, Vargas M . Snake venomics and antivenomics of Protobothrops mucrosquamatus and Viridovipera stejnegeri from Taiwan: keys to understand the variable immune response in horses. J Proteomics. 2012; 75(18):5628-45. DOI: 10.1016/j.jprot.2012.08.008. View

20.

De-Simone S, Napoleao-Pego P, Teixeira-Pinto L, Santos J, De-Simone T, Melgarejo A . Linear B-cell epitopes in BthTX-1, BthTX-II and BthA-1, phospholipase A₂'s from Bothrops jararacussu snake venom, recognized by therapeutically neutralizing commercial horse antivenom. Toxicon. 2013; 72:90-101. DOI: 10.1016/j.toxicon.2013.06.004. View